Scancell Holdings (GB:SCLP) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Scancell Holdings is set to raise at least £8.5 million through a new share placement and a director subscription, alongside a potential additional £1 million from a retail offer. This capital boost aims to support Scancell’s ongoing clinical trials and extend its cash runway, with promising early data from its cancer vaccine, SCIB1, showing significant patient responses. Investors in the biotech sector are likely to find this move an encouraging signal of future growth and innovation.
For further insights into GB:SCLP stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- An Always-On HBO Max for Warner Bros Discovery? (NASDAQ:WBD)
- Canadian Imperial Bank of Commerce (TSE:CM) Bursts Up After Posting Earnings
- Can Dogecoin Reach a New All-Time High? Here’s What This Analyst Expects
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
